Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery

September 28, 2011 updated by: Troels Haxholdt Lunn, Hvidovre University Hospital

Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery: An Prospective Observational Study

The purpose of this study is to evaluate patient related factors determining length of stay in hospital after arthroplasty surgery.

Study Overview

Status

Completed

Conditions

Detailed Description

To evaluate why the patient is in hospital after surgery, when predefined discharge criteria are met, which patient related clinical problems hinder fulfilling of the discharge criteria, and to evaluate actual length of stay in hospital.

All consecutive patients scheduled for total hip or knee arthroplasty are included in the trial.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
    • Hvidovre
      • Copenhagen, Hvidovre, Denmark, 2650
        • Hvidovre University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All consecutive patients scheduled for total hip or knee arthroplasty

Description

Inclusion Criteria:

  • Patients scheduled for total hip or knee arthroplasty

Exclusion Criteria:

  • Age under 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Patients with Osteoarthrosis
All consecutive patients scheduled for total hip or knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Patient related factors determining length of stay in hospital
Time Frame: Daily (average 2 days)
Daily (average 2 days)

Secondary Outcome Measures

Outcome Measure
Time Frame
Length of stay in hospital
Time Frame: At discharge (average 2 days)
At discharge (average 2 days)
Time till fulfilling of predefined discharge criteria
Time Frame: At discharge (average 2 days)
At discharge (average 2 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hvidovre University Hospital

Collaborators

Lundbeck Foundation

Investigators

  • Study Director: Henrik Husted, MD, Hvidovre University Hospital
  • Principal Investigator: Troels H. Lunn, M.D, Hvidovre University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

January 11, 2010

First Submitted That Met QC Criteria

January 11, 2010

First Posted (Estimate)

January 12, 2010

Study Record Updates

Last Update Posted (Estimate)

September 29, 2011

Last Update Submitted That Met QC Criteria

September 28, 2011

Last Verified

September 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1234 (Department of Defense)
  • 5678

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe